Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02600741 · ClinicalTrials.gov registry record

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

A clinical trial of Schizophrenia, sponsored by Janssen Scientific Affairs.

Completed
Registry status
296
Enrollment target
20
Study locations

NCT02600741 is a study of Schizophrenia that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 296 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (36% higher). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02600741, a study of Schizophrenia, has completed, sponsored by Janssen Scientific Affairs.

COMPLETED
Registry status
296 participants
Enrollment target
20
Study locations

Study Summary

The primary purpose of this study is to evaluate the overall effect of caregivers receiving a study-provided caregiver psycho-education and skills training program on the number of treatment failures (psychiatric hospitalization, psychiatric emergency room (ER) visit, crisis center visit, mobile crisis unit intervention, arrest/incarceration, and suicide or suicide attempt) in patients under their care during a 12 month period.

Conditions Studied

Schizophrenia

Interventions

  • DRUG Chlorpromazine
  • OTHER Caregiver psycho-education and skills training
  • OTHER Caregiver support available at the study site
  • DRUG Paliperidone palmitate
  • DRUG Droperidol

Study Locations (20)

Florida

  • - Lauderdale Lakes
  • - Leesburg
  • - Miami
  • - Orange City
  • - Tallahassee
  • - West Palm Beach

Illinois

  • - Granite City
  • - Lombard
  • - Springfield

Michigan

  • - Ann Arbor
  • - Grand Rapids
  • - Mount Pleasant

Indiana

  • - Bloomington
  • - Lawrenceburg

Arizona

  • - Bullhead City

California

  • - Oceanside

Colorado

  • - Denver

Connecticut

  • - Farmington

Trial Details

FieldValue
Enrollment Target 296 participants
Start Date 2015-07-24
Est. Completion 2018-07-05

Sponsor

Janssen Scientific Affairs

37 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02600741

The ClinicalTrials.gov registry entry for NCT02600741 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 296 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (36% higher). The listed sponsor is Janssen Scientific Affairs, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 5 interventions - of which Chlorpromazine is the first listed.

NCT02600741 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, Illinois, Michigan.

Frequently Asked Questions

What is clinical trial NCT02600741 about?

NCT02600741 is a clinical study titled "Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)". The primary purpose of this study is to evaluate the overall effect of caregivers receiving a study-provided caregiver psycho-education and skills training program on the number of treatment failures (psychiatric hospitalization, psychiatric emergency room (ER) visit, crisis center visit, mobile cri...

What is the current status of trial NCT02600741?

This trial is currently completed. The enrollment target is 296 participants. The study started on 2015-07-24. Estimated completion is 2018-07-05.

What conditions does trial NCT02600741 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT02600741?

The interventions under investigation include: Chlorpromazine (DRUG), Caregiver psycho-education and skills training (OTHER), Caregiver support available at the study site (OTHER), Paliperidone palmitate (DRUG), Droperidol (DRUG).

Who is sponsoring clinical trial NCT02600741?

This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02600741 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.